{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:26:29Z","timestamp":1786991189605,"version":"build-2736575974"},"reference-count":151,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jaad.2021.04.080","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T11:51:01Z","timestamp":1619783461000},"page":"1073-1090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Primary cutaneous T-cell lymphomas other than mycosis fungoides and S\u00e9zary syndrome. Part I: Clinical and histologic features and diagnosis"],"prefix":"10.1016","volume":"85","author":[{"given":"Joseph R.","family":"Stoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Willner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Pulitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Moskowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Myskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jaad.2021.04.080_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2013.08.033","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"10.1016\/j.jaad.2021.04.080_bib3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.12788\/j.sder.2018.001","article-title":"Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Kempf","year":"2018","journal-title":"Sem Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/17474086.2017.1270202","article-title":"Diagnostic, prognostic and therapeutic role of CD30 in lymphoma","volume":"10","author":"Pierce","year":"2017","journal-title":"Exp Rev Hematol"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00428-019-02713-7","article-title":"The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides\/Sezary syndrome","volume":"476","author":"Oschlies","year":"2020","journal-title":"Virch Arch"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jdv.15931","article-title":"Lymphomatoid papulosis: an update and review","volume":"34","author":"Martinez-Cabriales","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign\u2013histologically malignant","volume":"97","author":"Macaulay","year":"1968","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1046\/j.1365-2133.1999.03218.x","article-title":"Regional lymphomatoid papulosis: a report of four cases","volume":"141","author":"Scarisbrick","year":"1999","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib10","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/ijd.12719","article-title":"Localized lymphomatoid papulosis","volume":"54","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Int J Dermat"},{"issue":"9","key":"10.1016\/j.jaad.2021.04.080_bib11","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/jdv.12542","article-title":"Regional lymphomatoid papulosis in association with pseudoepitheliomatous hyperplasia: 13 years follow-up","volume":"29","author":"Wang","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaad.2009.01.034","article-title":"Localized lymphomatoid papulosis","volume":"62","author":"Hsu","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2009.02.025","article-title":"Acral lymphomatoid papulosis","volume":"62","author":"Yancovitz","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib14","first-page":"9","article-title":"Lymphomatoid papulosis localized to the face","volume":"12","author":"Dalle","year":"2006","journal-title":"Dermatol Online J"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/bjd.13092","article-title":"Lymphomatoid papulosis with 6p25.3 rearrangement: a further case of the newly described variant","volume":"171","author":"Kluk","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaad.2007.12.039","article-title":"Persistent agmination of lymphomatoid papulosis: not a new entity, but localized lymphomatoid papulosis","volume":"59","author":"Steinhoff","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jaad.2007.05.046","article-title":"Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma","volume":"57","author":"Heald","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1159\/000495689","article-title":"CD30-positive angioinvasive lymphomatoid papulosis (Type E) developing from parapsoriasis en plaque","volume":"11","author":"Fujimura","year":"2018","journal-title":"Case Rep Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2012.12.952","article-title":"Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings","volume":"68","author":"Kempf","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0190-9622(08)80202-2","article-title":"Pustular lymphomatoid papulosis in childhood","volume":"27","author":"Barnadas","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1067\/mjd.2001.102669","article-title":"Mucosal involvement in a patient with lymphomatoid papulosis","volume":"44","author":"Chimenti","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.04.080_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2230.2011.04046.x","article-title":"Bullous lymphomatoid papulosis","volume":"36","author":"Sureda","year":"2011","journal-title":"Clin Exper Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000081485","article-title":"Oral involvement in lymphomatoid papulosis","volume":"210","author":"Pujol","year":"2005","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"Cd30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.path.2014.02.001","article-title":"Cutaneous CD30-positive lymphoproliferative disorders","volume":"7","author":"Kempf","year":"2014","journal-title":"Surg Pathol Clin"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib26","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/1097-0142(19921215)70:12<2951::AID-CNCR2820701236>3.0.CO;2-7","article-title":"Epidemiology of lymphomatoid papulosis","volume":"70","author":"Wang","year":"1992","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40257-016-0192-6","article-title":"Lymphomatoid papulosis in children and adolescents: a systematic review","volume":"17","author":"Wieser","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib28","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2015.09.013","article-title":"Lymphomatoid papulosis: treatment response and associated lymphomas in a study of 180 patients","volume":"74","author":"Wieser","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.04.080_bib30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2230.2008.03024.x","article-title":"Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients","volume":"34","author":"Kunishige","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1634\/theoncologist.2015-0242","article-title":"Frequency and risk factors for associated lymphomas in patients with lymphomatoid papulosis","volume":"21","author":"Cordel","year":"2016","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/1203475417716366","article-title":"Associated hematolymphoid malignancies in patients with lymphomatoid papulosis: a Canadian retrospective study","volume":"21","author":"AbuHilal","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib33","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jaad.2011.07.012","article-title":"In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients","volume":"66","author":"de Souza","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"15","key":"10.1016\/j.jaad.2021.04.080_bib34","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib35","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3109\/10428194.2014.958821","article-title":"Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosis","volume":"56","author":"Nikolaou","year":"2015","journal-title":"Leuk Lymph"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1034\/j.1600-0560.2002.290507.x","article-title":"Fascin expression in CD30-positive cutaneous lymphoproliferative disorders","volume":"29","author":"Kempf","year":"2002","journal-title":"J Cutan Pathol"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.080_bib37","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archderm.140.4.441","article-title":"Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C","volume":"140","author":"El Shabrawi-Caelen","year":"2004","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.080_bib39","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.jaad.2021.04.080_bib41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mpdhp.2014.05.004","article-title":"The many faces of lymphomatoid papulosis","volume":"20","author":"Goodlad","year":"2014","journal-title":"Diagnost Histopathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.semdp.2016.11.005","article-title":"A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders","volume":"34","author":"Kempf","year":"2017","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib43","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2009.05.014","article-title":"Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients","volume":"61","author":"de Souza","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.04.080_bib44","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/DAD.0000000000000375","article-title":"Characterization of primary cutaneous CD8+\/CD30+ lymphoproliferative disorders","volume":"37","author":"Martires","year":"2015","journal-title":"Am J Dermatopath"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.080_bib45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJM198608213150802","article-title":"Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease","volume":"315","author":"Weiss","year":"1986","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jaad.2021.04.080_bib46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1600-0560.2006.00560.x","article-title":"Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders","volume":"33","author":"Greisser","year":"2006","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib47","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.0022-202X.2004.22304.x","article-title":"The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative)","volume":"122","author":"Gellrich","year":"2004","journal-title":"J Investig Dermaol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib48","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood-2001-12-0199","article-title":"Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin","volume":"100","author":"Steinhoff","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.semdp.2009.09.001","article-title":"Cutaneous CD30 lymphoproliferative disorders and similar conditions: a clinical and pathologic prospective on a complex issue","volume":"26","author":"Guitart","year":"2009","journal-title":"Sem Diagn Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bjd.13364","article-title":"\u03b3\u03b4 T-cell-rich variants of pityriasis lichenoides and lymphomatoid papulosis: benign cutaneous disorders to be distinguished from aggressive cutaneous \u03b3\u03b4 T-cell lymphomas","volume":"172","author":"Martinez-Escala","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib51","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/his.13671","article-title":"T-cell receptor-\u03b4 expression and \u03b3\u03b4+ T-cell infiltrates in primary cutaneous \u03b3\u03b4 T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders","volume":"73","author":"Pulitzer","year":"2018","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0037-1963(03)00138-0","article-title":"Systemic and primary cutaneous anaplastic large cell lymphomas","volume":"40","author":"Kadin","year":"2003","journal-title":"Sem Hematol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib53","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.1995.13.6.1343","article-title":"CD30\/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group","volume":"13","author":"Paulli","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2021.04.080_bib54","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1097\/PRS.0000000000005567","article-title":"Current risk estimate of breast implant\u2013associated anaplastic large cell lymphoma in textured breast implants","volume":"143","author":"Collett","year":"2019","journal-title":"Plast Recon Surg"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib55","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bjps.2019.11.064","article-title":"Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants","volume":"73","author":"Cordeiro","year":"2020","journal-title":"J Plast Recon Aesth Surg"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib56","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/PRS.0000000000003282","article-title":"U.S. Epidemiology of breast implant-associated anaplastic large cell lymphoma","volume":"139","author":"Doren","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2021.04.080_bib57","doi-asserted-by":"crossref","first-page":"101963","DOI":"10.1016\/j.ctrv.2020.101963","article-title":"Breast implant-associated anaplastic large cell lymphoma: a comprehensive review","volume":"84","author":"Marra","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"18","key":"10.1016\/j.jaad.2021.04.080_bib58","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1182\/blood-2018-03-785972","article-title":"How I treat breast implant\u2013associated anaplastic large cell lymphoma","volume":"132","author":"Mehta-Shah","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.080_bib59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib60","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/asj\/sjy331","article-title":"2019 NCCN Consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"39","author":"Clemens","year":"2019","journal-title":"Aesth Surg J"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib61","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/cup.12937","article-title":"Primary cutaneous anaplastic large cell lymphoma","volume":"44","author":"Brown","year":"2017","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib62","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.path.2019.03.006","article-title":"Recent advances\u00a0in\u00a0cutaneous T-cell lymphoma: diagnostic and\u00a0prognostic considerations","volume":"12","author":"Cocks","year":"2019","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/cco.2018.12.03","article-title":"The spectrum of CD30+ T cell lymphoproliferative disorders in the skin","volume":"8","author":"Kartan","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib64","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/DAD.0b013e3182a5683a","article-title":"Phenotypic variability in primary cutaneous anaplastic large T-cell lymphoma: a study on 35 patients","volume":"36","author":"Massone","year":"2014","journal-title":"Am J Dermatopath"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib66","first-page":"1893","article-title":"TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation","volume":"150","author":"Felgar","year":"1997","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib67","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12185-010-0708-4","article-title":"A case of anaplastic large cell lymphoma, ALK positive, primary presented in the skin and relapsed with systemic involvement and leukocytosis after years of follow-up period","volume":"92","author":"Hosoi","year":"2010","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000478-199101000-00002","article-title":"T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome","volume":"15","author":"Gonzalez","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib69","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2018.05.1243","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: clinical features, therapeutic approach, and outcome in a case series of 16 patients","volume":"79","author":"L\u00f3pez-Lerma","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib70","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib71","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.det.2008.05.008","article-title":"Subcutaneous panniculitic-like T-cell lymphoma and other primary cutaneous lymphomas with prominent subcutaneous tissue involvement","volume":"26","author":"Gallardo","year":"2008","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2478\/v10019-012-0017-z","article-title":"Usefulness of F-18 FDG PET\/CT in subcutaneous panniculitis-like T cell lymphoma: disease extent and treatment response evaluation","volume":"46","author":"Kim","year":"2012","journal-title":"Radiol Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/cup.12436","article-title":"Systemic panniculitis-like T-cell lymphoma with involvement of mesenteric fat and subcutis","volume":"42","author":"Lester","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib74","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1684\/ejd.2016.2914","article-title":"Clinical characteristics, differential diagnosis, and treatment outcome of subcutaneous panniculitis-like T-cell lymphoma: a literature review of published Japanese cases","volume":"27","author":"Ohtsuka","year":"2017","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib75","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2340\/00015555-2543","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: immunosuppressive drugs induce better response than polychemotherapy","volume":"97","author":"Michonneau","year":"2017","journal-title":"Acta Dermat Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00000372-200106000-00008","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: an elusive case presenting as lipomembranous panniculitis and a review of 72 cases in the literature","volume":"23","author":"Weenig","year":"2001","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib77","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.pas.0000126719.71954.4f","article-title":"Subcutaneous, blastic natural killer (NK), NK\/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients","volume":"28","author":"Massone","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib78","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1365-2133.2003.05226.x","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients","volume":"148","author":"Hoque","year":"2003","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib79","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5858\/133.2.303","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas","volume":"133","author":"Parveen","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib80","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1600-0560.2001.028005235.x","article-title":"Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia","volume":"28","author":"Magro","year":"2001","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib82","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.0303-6987.2005.00331.x","article-title":"Fatal subcutaneous panniculitis-like T-cell lymphoma with interface change and dermal mucin, a dead ringer for lupus erythematosus","volume":"32","author":"Ma","year":"2005","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib83","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/DAD.0b013e3181b4a5ec","article-title":"Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies","volume":"32","author":"Park","year":"2010","journal-title":"Am J Dermatopath"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/cco.2018.11.01","article-title":"Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literature","volume":"8","author":"Geller","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"7","key":"10.1016\/j.jaad.2021.04.080_bib85","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/his.12105","article-title":"The presence of clusters of plasmacytoid dendritic cells is a helpful feature for differentiating lupus panniculitis from subcutaneous panniculitis-like T-cell lymphoma","volume":"62","author":"Liau","year":"2013","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib86","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/PAS.0000000000000596","article-title":"Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis","volume":"40","author":"LeBlanc","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib87","doi-asserted-by":"crossref","first-page":"39","DOI":"10.12788\/j.sder.2018.006","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Gru","year":"2018","journal-title":"Sem Cutan Med Surg"},{"issue":"20","key":"10.1016\/j.jaad.2021.04.080_bib89","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":"Primary cutaneous small\/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib90","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jaad.2018.05.033","article-title":"Management of primary cutaneous CD4+ small and medium pleomorphicT-cell lymphoma: a retrospective study","volume":"79","author":"Yuan","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib91","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/cup.12806","article-title":"Clinicopathological and molecular study of primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma","volume":"43","author":"Alberti-Violetti","year":"2016","journal-title":"J Cutan Pathol"},{"issue":"11","key":"10.1016\/j.jaad.2021.04.080_bib92","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ijd.13340","article-title":"Long-term follow-up and management of small and medium-sized CD4(+) T cell lymphoma and CD8(+) lymphoid proliferations of acral sites: a multicenter experience","volume":"55","author":"Virmani","year":"2016","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib93","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib94","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2010.07.028","article-title":"Reappraisal of the provisional entity primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature","volume":"65","author":"Baum","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib95","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5045\/br.2017.52.4.326","article-title":"Differential diagnosis of primary cutaneous CD4+ small\/medium T-cell lymphoproliferative lesions: a report of three cases","volume":"52","author":"Kim","year":"2017","journal-title":"Blood Res"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib96","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2002-07-1960","article-title":"Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients","volume":"102","author":"Bekkenk","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib88","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphicT-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib97","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1203475417715209","article-title":"Primary cutaneous CD4(+) small\/medium pleomorphic T-cell lymphoproliferative disorder: a case series","volume":"21","author":"Maurelli","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib98","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/10428194.2014.938331","article-title":"CD4 + primary cutaneous small\/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature","volume":"56","author":"James","year":"2015","journal-title":"Leuk Lymph"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib99","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","article-title":"Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma","volume":"36","author":"Cetin\u00f6zman","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodr\u00edguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib101","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cup.12633","article-title":"Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient","volume":"43","author":"Kluk","year":"2016","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib103","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J Cutan Pathol"},{"issue":"9","key":"10.1016\/j.jaad.2021.04.080_bib104","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/DAD.0000000000001366","article-title":"Primary cutaneous acral CD8+ T-cell lymphoma\u2014A single center review of 3 cases and recent literature review","volume":"41","author":"Tjahjono","year":"2019","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"10.1016\/j.jaad.2021.04.080_bib105","first-page":"1469","article-title":"Primary ctaneous acral CD8+ T-cell","volume":"141","author":"Hathuc","year":"2017","journal-title":"Lymphoma"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/DAD.0b013e31825c3a33","article-title":"Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification","volume":"35","author":"Kempf","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib107","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/bjd.13628","article-title":"CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas","volume":"172","author":"Wobser","year":"2015","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib108","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/modpathol.2016.240","article-title":"Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas","volume":"30","author":"Guitart","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib109","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/his.12371","article-title":"Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop","volume":"67","author":"Robson","year":"2015","journal-title":"Histopathology"},{"issue":"20","key":"10.1016\/j.jaad.2021.04.080_bib111","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib112","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaad.2009.02.035","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma","volume":"62","author":"Gormley","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib113","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0190-9622(90)70074-R","article-title":"Cutaneous T cell lymphoma with suppressor\/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes","volume":"22","author":"Agnarsson","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.04.080_bib114","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/ijd.14017","article-title":"Diffuse eruptive ulcerated plaques","volume":"57","author":"Geller","year":"2018","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.080_bib115","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archderm.144.8.1027","article-title":"CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement","volume":"144","author":"Introcaso","year":"2008","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib116","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cll.2017.06.006","article-title":"Cutaneous T-cell Lymphoma","volume":"37","author":"Pulitzer","year":"2017","journal-title":"Clin Lab Med"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib117","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2011.07.043","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation","volume":"67","author":"Nofal","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib118","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12788\/j.sder.2018.015","article-title":"NK\/T-cell lymphoma, nasal type, \u03b3\u03b4 T-cell lymphoma, and CD8-positive epidermotropic T-cell lymphoma-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Geller","year":"2018","journal-title":"Sem Cutan Med Surg"},{"issue":"11","key":"10.1016\/j.jaad.2021.04.080_bib119","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous \u03b3\u03b4 T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.jaad.2021.04.080_bib120","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.080_bib121","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"\u03b3\u03b4 T-cell lymphoma of the skin: a clinical, microscopic, and molecular study","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib122","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"10.1016\/j.jaad.2021.04.080_bib123","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/jamadermatol.2018.1264","article-title":"Hemophagocytic lymphohistiocytosis in cutaneous T-cell lymphoma","volume":"154","author":"Lee","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib124","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/cup.12830","article-title":"\u03b3\u03b4 T-cell in cutaneous and subcutaneous lymphoid infiltrates: malignant or not?","volume":"43","author":"Guitart","year":"2016","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2559.2000.00893.x","article-title":"gammadelta T-cell lymphomas: a homogeneous entity?","volume":"36","author":"de Wolf-Peeters","year":"2000","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib126","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/1523-1747.ep12470953","article-title":"Primary cutaneous gamma\/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis","volume":"96","author":"Berti","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib127","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/ejh.12439","article-title":"Gamma-delta t-cell lymphomas","volume":"94","author":"Foppoli","year":"2015","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib128","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-020-15572-7","article-title":"Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas","volume":"11","author":"Daniels","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib129","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/PAS.0000000000000768","article-title":"Primary cutaneous T-cell lymphomas showing gamma-delta (\u03b3\u03b4) phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous \u03b3\u03b4 T-cell lymphomas","volume":"41","author":"Merrill","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib130","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood.V78.12.3269.3269","article-title":"Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia","volume":"78","author":"Matutes","year":"1991","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib131","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/annonc\/mdi037","article-title":"Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years","volume":"16","author":"Au","year":"2005","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1016\/j.jaad.2021.04.080_bib132","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib133","first-page":"38","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru","volume":"15","author":"Barrionuevo","year":"2007","journal-title":"AIMM"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib134","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bjh.12659","article-title":"Differences in incidence and trends of haematological malignancies in Japan and the United States","volume":"164","author":"Chihara","year":"2014","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.jaad.2021.04.080_bib135","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1182\/blood-2012-07-440073","article-title":"Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases","volume":"120","author":"Laurini","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib136","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","article-title":"Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/T-cell or T-cell lymphoma","volume":"100","author":"Li","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib137","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2009.07802.x","article-title":"Advances in the management and monitoring of extranodal NK\/T-cell lymphoma, nasal type","volume":"147","author":"Liang","year":"2009","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib138","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11899-016-0355-9","article-title":"Extranodal NK\/T cell lymphoma, nasal type (ENKTL-NT): an update on epidemiology, clinical presentation, and natural history in North American and European cases","volume":"11","author":"Haverkos","year":"2016","journal-title":"Curr Hematol Malignan Rep"},{"key":"10.1016\/j.jaad.2021.04.080_bib139","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fped.2018.00417","article-title":"Overview of EBV-associated T\/NK-cell lymphoproliferative diseases","volume":"6","author":"Kimura","year":"2019","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.080_bib140","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","article-title":"Clinical features of adult-onset chronic active Epstein\u2013Barr virus infection: a retrospective analysis","volume":"93","author":"Arai","year":"2011","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.080_bib141","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","article-title":"A distinct subtype of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features","volume":"103","author":"Keisuke","year":"2018","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.080_bib142","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaad.2014.10.006","article-title":"Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia\/lymphoma: a single-center, retrospective study","volume":"72","author":"Marchetti","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib143","first-page":"336","article-title":"HTLV-1 and associated adult T-cell leukemia\/lymphoma","volume":"7","author":"Mahieux","year":"2003","journal-title":"Rev Clin Exp Hematol"},{"issue":"11","key":"10.1016\/j.jaad.2021.04.080_bib144","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib145","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2005-03-1083","article-title":"Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?","volume":"106","author":"Grogg","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.080_bib146","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood-2006-01-0394","article-title":"Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells","volume":"108","author":"Krenacs","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib147","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T Cells","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.080_bib148","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"13","author":"R\u00fcdiger","year":"2002","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.080_bib149","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/DAD.0000000000000144","article-title":"Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics","volume":"37","author":"Botros","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2021.04.080_bib150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1746-1596-7-7","article-title":"Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature","volume":"7","author":"Yang","year":"2012","journal-title":"Diagnos Pathol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.080_bib151","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/DAD.0000000000001371","article-title":"Epstein-Barr virus-induced cutaneous diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-Cell Lymphoma","volume":"41","author":"Poon","year":"2019","journal-title":"Am J Dermatopathol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221009269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221009269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:59:59Z","timestamp":1759273199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221009269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":151,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0190962221009269"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.04.080","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740050085.793585534","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary cutaneous T-cell lymphomas other than mycosis fungoides and S\u00e9zary syndrome. Part I: Clinical and histologic features and diagnosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.04.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(21)02463-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}